1. Academic Validation
  2. NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication

NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication

  • PLoS Pathog. 2023 Dec 4;19(12):e1011808. doi: 10.1371/journal.ppat.1011808.
Jiangpeng Feng 1 Tianmo Xu 1 2 Miao He 1 3 Jiali Li 1 Peipei Yao 2 4 Chengbao Ma 1 Shimin Yang 1 Zaichao Xu 4 Kun Yan 1 Xianying Chen 1 Hongyun Wang 1 Jiejie Liu 1 Cong Zeng 5 Yuchen Xia 4 Huan Yan 1 Li Zhou 1 2 4 Yu Chen 1 2
Affiliations

Affiliations

  • 1 State Key Laboratory of Virology, RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
  • 2 Animal Bio-safety Level III Laboratory/Institute for Vaccine Research, Wuhan University School of Medicine, Wuhan, China.
  • 3 School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • 4 Wuhan University Taikang Medical School (School of Basic Medical Sciences), Wuhan, China.
  • 5 School of Basic Medical Sciences, Fudan University, Shanghai, China.
Abstract

Chronic hepatitis B virus (HBV) Infection is a major cause of liver cirrhosis and liver Cancer, despite strong prevention and treatment efforts. The study of the epigenetic modification of HBV has become a research hotspot, including the N6-methyladenosine (m6A) modification of HBV RNA, which plays complex roles in the HBV life cycle. In addition to m6A modification, 5-methylcytosine (m5C) is another major modification of eukaryotic mRNA. In this study, we explored the roles of m5C methyltransferase and demethyltransferase in the HBV life cycle. The results showed that m5C methyltransferase NSUN2 deficiency could negatively regulate the expression of HBV while m5C demethyltransferase TET2 deficiency positively regulates the expression of HBV. Subsequently, we combined both in vitro bisulfite Sequencing and high-throughput bisulfite Sequencing methods to determine the distribution and stoichiometry of m5C modification in HBV RNA. Two sites: C2017 and C131 with the highest-ranking methylation rates were identified, and mutations at these two sites could lead to the decreased expression and replication of HBV, while the mutation of the "fake" m5C site had no effect. Mechanistically, NSUN2-mediated m5C modification promotes the stability of HBV RNA. In addition, compared with wild-type HepG2-NTCP cells and primary human hepatocytes, the replication level of HBV after NSUN2 knockdown decreased, and the ability of the mutant virus to infect and replicate in wild-type HepG2-NTCP cells and PHHs was substantially impaired. Similar results were found in the experiments using C57BL/6JGpt-Nsun2+/- mice. Interestingly, we also found that HBV expression and core protein promoted the endogenous expression of NSUN2, which implied a positive feedback loop. In summary, our study provides an accurate and high-resolution m5C profile of HBV RNA and reveals that NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication by maintaining RNA stability.

Figures
Products
Inhibitors & Agonists
Other Products